Therapeutic effect of linac-based stereotactic radiotherapy with a micro-multileaf collimator for the treatment of patients with brain metastases from lung cancer

Japanese Journal of Clinical Oncology

Volumn 40, Issue 2, 2010, Pages 119-124

  Saitoh, Jun Ichi ^a   Saito, Yoshihiro ^a   Kazumoto, Tomoko ^a   Kudo, Shigehiro ^a   Ichikawa, Akihiro ^a   Hayase, Nobuaki ^a   Kazumoto, Kiyoshi ^a   Sakai, Hiroshi ^a   Shibuya, Kei ^b  

^a SAITAMA CANCER CENTER   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain metastases; Hypofractionated; Lung cancer; Micro multileaf collimator; Stereotactic radiotherapy

Indexed keywords

AGED; ARTICLE; BRAIN METASTASIS; BRAIN NECROSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COLLIMATOR; FEMALE; HUMAN; HUMAN TISSUE; LINEAR ACCELERATOR; LUNG CANCER; MALE; PATIENT CARE PLANNING; PATIENT SAFETY; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STEREOTACTIC RADIOTHERAPY; SURVIVAL RATE; SURVIVAL TIME; BRAIN TUMOR; DISEASE FREE SURVIVAL; INTENSITY MODULATED RADIATION THERAPY; LUNG TUMOR; METASTASIS; MIDDLE AGED; RADIOGRAPHY; RADIOSURGERY;

AGED; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 77449127329     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp128     Document Type: Article

References (14)

1. Breneman JC, Warnick RE, Albright RE, Kukiatinant N, Shaw J, Armin D, et al. Stereotactic radiosurgery for the treatment of brain metastases. Cancer 1997;79:551-7.
2. Shiau C-Y, Sneed PK, Shu H-KG, Lamborn KR, McDermott MW, Chang S, et al. Radiosurgery for brain metastases: relationship of dose and pattern of enhancement to local control. Int J Radiat Oncol Biol Phys 1997;37:375-83.
3. Manning MA, Cardinale RM, Benedict SH, Kavanagh BD, Zwicker RD, Amir C, et al. Hypofractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys 2000;47:603-8.
4. Tokuuye K, Akine Y, Sumi M, Kagami Y, Murayama S, Nakayama H, et al. Fractionated stereotactic radiotherapy of small intracranial malignancies. Int J Radiat Oncol Biol Phys 1998;42:989-94.
5. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized control trial. JAMA 2006;295:2483-91.
6. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trial. Int J Radiat Oncol Biol Phys 1997;37:745-51.
7. Kurtz JM, Gelber R, Brady LW, Carella RJ, Cooper JS. The palliation of brain metastases in a favorable patient population: a randomized clinical trial by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981;7:891-5.
8. Komarnicky LT, Phillips TL, Martz K, Asbell S, Isaacson S, Urtasun R. A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991;20:53-8.
9. Aoyama H, Shirato H, Onimaru R, Kagei K, Ikeda J, Ishii N, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys 2003;56:793-800.
10. Lindvall P, BergströmP,Löfroth PO, Henriksson R, Bergenheim AT. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys 2005;61:1460-6.
11. Ernst-Stecken A, Ganslandt O, Lambrecht U, Sauer R, Grabenbauer G. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol 2006;81:18-24.
12. Fahrig A, Ganslandt O, Lambrecht U, Grabenbauer G, Kleinert G, Sauer R, et al. Hypofractionated stereotactic radiotherapy for brain metastases-results from three different dose concepts. Strahlenther Onkol 2007;183:625-30.
13. Kwon AK, Dibiase SJ, Wang B, Hughes SL, Milcarek B, Zhu Y. Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. Cancer 2009;115:890-8. 15.
14. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gasper LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet 2004;363:1665-72.